Aclarion Stock Price To Earnings To Growth
| ACON Stock | USD 0.18 0.01 5.88% |
Aclarion fundamentals help investors to digest information that contributes to Aclarion's financial success or failures. It also enables traders to predict the movement of Aclarion Stock. The fundamental analysis module provides a way to measure Aclarion's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aclarion stock.
Aclarion | Price To Earnings To Growth |
Aclarion Company Price To Earnings To Growth Analysis
Aclarion's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Aclarion Price To Earnings To Growth Driver Correlations
Understanding the fundamental principles of building solid financial models for Aclarion is extremely important. It helps to project a fair market value of Aclarion Stock properly, considering its historical fundamentals such as Price To Earnings To Growth. Since Aclarion's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aclarion's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aclarion's interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Aclarion Price Earnings To Growth Ratio
Price Earnings To Growth Ratio |
|
Based on the latest financial disclosure, Aclarion has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and about the same as Health Care (which currently averages 0.0) industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Aclarion Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aclarion's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aclarion could also be used in its relative valuation, which is a method of valuing Aclarion by comparing valuation metrics of similar companies.Aclarion is currently under evaluation in price to earnings to growth category among its peers.
Aclarion Fundamentals
| Return On Equity | -7.14 | ||||
| Return On Asset | -1.15 | ||||
| Operating Margin | (103.51) % | ||||
| Current Valuation | 1.45 M | ||||
| Shares Outstanding | 10.43 M | ||||
| Shares Owned By Insiders | 9.76 % | ||||
| Shares Owned By Institutions | 3.57 % | ||||
| Number Of Shares Shorted | 380.86 K | ||||
| Price To Book | 0.74 X | ||||
| Price To Sales | 34.26 X | ||||
| Revenue | 75.4 K | ||||
| Gross Profit | (4.85 K) | ||||
| EBITDA | (4.14 M) | ||||
| Net Income | (4.91 M) | ||||
| Cash And Equivalents | 3.79 M | ||||
| Cash Per Share | 0.49 X | ||||
| Total Debt | 1.13 M | ||||
| Current Ratio | 3.18 X | ||||
| Book Value Per Share | (0.88) X | ||||
| Cash Flow From Operations | (3.65 M) | ||||
| Short Ratio | 0.77 X | ||||
| Earnings Per Share | (2.40) X | ||||
| Target Price | 1.15 | ||||
| Beta | 0.4 | ||||
| Market Capitalization | 1.85 M | ||||
| Total Asset | 2.46 M | ||||
| Retained Earnings | (44.28 M) | ||||
| Working Capital | (1.9 M) | ||||
| Net Asset | 2.46 M |
About Aclarion Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aclarion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aclarion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aclarion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Aclarion is a strong investment it is important to analyze Aclarion's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aclarion's future performance. For an informed investment choice regarding Aclarion Stock, refer to the following important reports: Check out Aclarion Piotroski F Score and Aclarion Altman Z Score analysis. To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aclarion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.40) | Revenue Per Share 0.015 | Quarterly Revenue Growth (0.36) | Return On Assets (1.15) | Return On Equity (7.14) |
The market value of Aclarion is measured differently than its book value, which is the value of Aclarion that is recorded on the company's balance sheet. Investors also form their own opinion of Aclarion's value that differs from its market value or its book value, called intrinsic value, which is Aclarion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aclarion's market value can be influenced by many factors that don't directly affect Aclarion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aclarion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aclarion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aclarion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.